CINC

CinCor Pharma, Inc. Common Stock

Delisted

CINC was delisted on the 23rd of February, 2023.

57 hedge funds and large institutions have $596M invested in CinCor Pharma, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 24 increasing their positions, 12 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
57
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$11.1M
2 +$9.18M
3 +$3.56M
4
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$3.32M
5
BlackRock
BlackRock
New York
+$3.13M

Top Sellers

1 -$1.71M
2 -$1.32M
3 -$740K
4
PHK
Point72 Hong Kong
Hong Kong
-$387K
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$328K
Name Holding Trade Value Shares
Change
Change in
Stake
26
$787K
27
$766K
28
$655K
29
$586K
30
$552K
31
$497K
32
$434K
33
$432K
34
$360K
35
$330K
36
$321K
37
$215K
38
$202K
39
$192K
40
$180K
41
$152K
42
$118K
43
$107K
44
$95K
45
$81K
46
$50K
47
$40K
48
$24K
49
$17.9K
50
$16K